Director of the Department of Infectious Diseases and Director of the Guangdong Provincial Institute of Liver Diseases
Affiliated HospitalSouthern Medical University Southern Hospital
→
Research areas : Clinical diagnosis and treatment of liver diseases and translational medicine research; discovery and translation of new curative strategies and targets for chronic hepatitis B; zero mother-to-child transmission of hepatitis B.
Cutting-edge technologies: The NEJM-published clinical cure regimen for hepatitis B using Xalnesiran combined with immunomodulators (cure rate over 30%, with 47% of patients having low baseline HBsAg); the GOLDEN predictive model (identifying the high-risk group for cure 19 months in advance); and the hepatitis B mother-to-child transmission zero transmission project (a Chinese protocol recognized by the WHO).
Diseases specializing in: chronic hepatitis B, hepatitis C, cirrhosis, liver cancer, and end-stage liver disease.
Academic Highlights: Recipient of the National Science Fund for Distinguished Young Scholars (200; President of the 2nd Asia-Pacific Association for the Study of the Liver (2017), Chairman of the Infectious Diseases Branch of the Chinese Medical Association (2013-201); Member of the Academic Degrees Committee of the State Council, Vice Chairman of the China Foundation for Hepatitis Prevention and Control; Chief Scientist of the National Science and Technology Major Project from the 11th Five-Year Plan to the 13th Five-Year Plan; Two Second Prizes of the National Science and Technology Progress Award, Four First Prizes of the Guangdong Provincial Science and Technology Progress Award; Published nearly 00 papers (including NEJM, Science, Nature Medicine, J Hepatol, Gut); Elsevier "Highly Cited Chinese Researcher" for seven consecutive years.